Risk factors for ICI-associated AKI include younger age [53], lower baseline glomerular filtration rate, anti-CTLA4 and most importantly anti-CTLA4/anti-PD1 combination therapy [57]. The gene discussed is PDCD1; the disease is acute kidney injury.